Literature DB >> 22806334

Evaluation of pharmacokinetic differences of acetaminophen in pseudo germ-free rats.

Soo Hyun Lee1, Ji Hye An, Hwa Jeong Lee, Byung Hwa Jung.   

Abstract

To evaluate the metabolic interaction between host and gut microflora on drug metabolism, pseudo germ-free rats were prepared with an antibiotics cocktail to change their gut conditions. The usefulness of the pseudo germ-free model was evaluated for observing the DMPK of acetaminophen (APAP). Pseudo germ-free rats were prepared by orally administering antibiotic cocktails consisting of bacitracin, streptomycin and neomycin, and then APAP was orally administered to control and pseudo germ-free rats. The plasma concentration of APAP and its six metabolites were quantified using a validated LC-MS/MS method. A non-compartment model estimated the pharmacokinetic parameters of APAP and its metabolites, and the ratios of the area under curve (AUC; AUC(metabolite) /AUC(APAP) ) were also observed to evaluate the change of APAP metabolism. The AUCs of APAP and APAP-Glth (glutathione) were higher and the AUC(APAP-Sul) /AUC(APAP) (metabolic efficiency of sulfate conjugation) was lower in pseudo germ-free rats than those in the control rats. The decrease in metabolic efficiency of sulphate conjugation could result from the reduction of the sulphate supply, causing an increase of the AUC of APAP and APAP-Glth. The activities of gut microflora can affect the state of hepatic sulphate for drug conjugation, indirectly leading to characteristic APAP metabolism. These results indicate that gut microflora may play an important role in the pharmacokinetics and metabolism of APAP. Thus, the metabolic interaction between host and gut microflora should be considered upon drug administration and pseudo germ-free rats prepared in the present study can be competent for investigating the metabolic interaction between host and gut microflora on drug metabolism.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22806334     DOI: 10.1002/bdd.1799

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  6 in total

Review 1.  Gut microbiome interactions with drug metabolism, efficacy, and toxicity.

Authors:  Ian D Wilson; Jeremy K Nicholson
Journal:  Transl Res       Date:  2016-08-13       Impact factor: 7.012

Review 2.  The influence of gut microbiota on drug metabolism and toxicity.

Authors:  Houkai Li; Jiaojiao He; Wei Jia
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-12-10       Impact factor: 4.481

3.  Mass Spectrometry in Pharmacokinetic Studies of a Synthetic Compound for Spinal Cord Injury Treatment.

Authors:  María Sánchez-Sierra; Isabel García-Álvarez; Alfonso Fernández-Mayoralas; Sandra Moreno-Lillo; Gemma Barroso García; Verónica Moral Dardé; Ernesto Doncel-Pérez
Journal:  Biomed Res Int       Date:  2015-05-19       Impact factor: 3.411

4.  Manipulation of the Gut Microbiome Alters Acetaminophen Biodisposition in Mice.

Authors:  Michael A Malfatti; Edward A Kuhn; Deepa K Murugesh; Melanie E Mendez; Nicholas Hum; James B Thissen; Crystal J Jaing; Gabriela G Loots
Journal:  Sci Rep       Date:  2020-03-12       Impact factor: 4.379

5.  Vibrio parahaemolyticus Infection in Mice Reduces Protective Gut Microbiota, Augmenting Disease Pathways.

Authors:  Rundong Wang; Yijia Deng; Qi Deng; Dongfang Sun; Zhijia Fang; Lijun Sun; Yaling Wang; Ravi Gooneratne
Journal:  Front Microbiol       Date:  2020-01-30       Impact factor: 5.640

Review 6.  Association of antioxidant nutraceuticals and acetaminophen (paracetamol): Friend or foe?

Authors:  Mohamed Abdel-Daim; Abdelrahman Ibrahim Abushouk; Raffaella Reggi; Nagendra Sastry Yarla; Maura Palmery; Ilaria Peluso
Journal:  J Food Drug Anal       Date:  2017-12-16       Impact factor: 6.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.